Symptoms and ocular findings associated with administration of 0.01% atropine in young adults

References

• Brodstein RS, Brodstein DE, Olson RJ, et al. The treatment of myopia with atropine and bifocals. A long-term prospective study. Ophthalmology 1984; 91: 1373–1379.
   PubMed Web of Science ®Google Scholar
• Yen MY, Liu JH, Kao SC, et al. Comparison of the effect of atropine and cyclopentolate on myopia. Ann Ophthalmol. 1989; 21: 180–182, 187.
   PubMedGoogle Scholar
• Shih YF, Chen CH, Chou AC, et al. Effects of different concentrations of atropine on controlling myopia in myopic children. J Ocul Pharmacol Ther 1999; 15: 85–90.
   PubMed Web of Science ®Google Scholar
• Chua WH, Balakrishnan V, Chan YH, et al. Atropine for the treatment of childhood myopia. Ophthalmology 2006; 113: 2285–2291.
   PubMed Web of Science ®Google Scholar
• Yi S, Huang Y, Yu SZ, et al. Therapeutic effect of atropine 1% in children with low myopia. J AAPOS 2015; 19: 426–429.
   PubMed Web of Science ®Google Scholar
• Chia A, Chua WH, Cheung YB, et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2). Ophthalmology 2012; 119: 347–354.
   PubMed Web of Science ®Google Scholar
• Chia A, Chua WH, Wen L, et al. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%. Am J Ophthalmol 2014; 157: 451–457 e451.
   PubMed Web of Science ®Google Scholar
• Clark TY, Clark RA. Atropine 0.01% eyedrops significantly reduce the progression of childhood myopia. J Ocul Pharmacol Ther 2015; 31: 541–545.
   PubMed Web of Science ®Google Scholar
• Chia A, Lu Q-S., Tan D. Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2. Ophthalmology 2016; 123: 391–399.
   PubMed Web of Science ®Google Scholar
• Diaz-Llopis M, Pinazo-Durán MD. Superdiluted atropine at 0.01% reduces progression in children and adolescents. A 5 year study of safety and effectiveness. Arch Soc Esp Oftalmol 2018; 93: 182–185.
   PubMedGoogle Scholar
• Larkin GL, Tahir A, Epley KD, et al. Atropine 0.01% eye drops for myopia control in American children: a multiethnic sample across three US sites. Ophthalmol Ther 2019; 8: 589–598.
   PubMed Web of Science ®Google Scholar
• Yam JC, Jiang Y, Tang SM, et al. Low-Concentration Atropine for Myopia Progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control. Ophthalmology 2019; 126: 113–124.
   PubMed Web of Science ®Google Scholar
• Wei S, Li SM, An W, et al. Safety and efficacy of low-dose atropine eyedrops for the treatment of myopia progression in Chinese children: a randomized clinical trial. JAMA Ophthalmol. 2020; 138: 1178.
   PubMed Web of Science ®Google Scholar
• Yam JC, Li FF, Zhang X, et al. Two-year clinical trial of the Low-Concentration Atropine for Myopia Progression (LAMP) study: phase 2 report. Ophthalmology 2020; 127: 910–919.
   PubMed Web of Science ®Google Scholar
• Fang PC, Chung MY, Yu HJ, et al. Prevention of myopia onset with 0.025% atropine in premyopic children. J Ocul Pharmacol Ther 2010; 26: 341–345.
   PubMed Web of Science ®Google Scholar
• Loughman J, Flitcroft DI. The acceptability and visual impact of 0.01% atropine in a Caucasian population. Br J Ophthalmol 2016; 100: 1525–1529.
   PubMed Web of Science ®Google Scholar
• Yu TC, Wu TE, Wang YS, et al. A STROBE-compliant case-control study: effects of cumulative doses of topical atropine on intraocular pressure and myopia progression. Medicine (Baltimore). 2020; 99: e22745.
   PubMed Web of Science ®Google Scholar
• Wu TE, Chen HA, Jhou MJ, et al. Evaluating the effect of topical atropine use for myopia control on intraocular pressure by using machine learning. J Clin Med 2020; 10: 111.
   PubMed Web of Science ®Google Scholar
• Walline JJ, Walker MK, Mutti DO, et al. Effect of high add power, medium add power, or single-vision contact lenses on myopia progression in children: the BLINK randomized clinical trial. JAMA 2020; 324: 571–580.
   PubMed Web of Science ®Google Scholar
• Berntsen DA, Sinnott LT, Mutti DO, et al. A randomized trial using progressive addition lenses to evaluate theories of myopia progression in children with a high lag of accommodation. Invest Ophthalmol Vis Sci 2012; 53: 640–649.
   PubMed Web of Science ®Google Scholar
• Mutti DO, Mitchell GL, Hayes JR, et al. Accommodative lag before and after the onset of myopia. Invest Ophthalmol Vis Sci 2006; 47: 837–846.
   PubMed Web of Science ®Google Scholar
• Mutti DO, Jones LA, Moeschberger ML, et al. AC/A ratio, age, and refractive error in children. Invest Ophthalmol Vis Sci 2000; 41: 2469–2478.
   PubMed Web of Science ®Google Scholar
• Wilkins AJ, Jeanes RJ, Pumfrey PD, et al. Rate of Reading Test(R): its reliability, and its validity in the assessment of the effects of coloured overlays. Ophthalmic Physiol Optics. 1996; 16: 491–497.
   PubMed Web of Science ®Google Scholar
• Fu A, Stapleton F, and Wei L, et al. Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression. Br J Ophthalmol 2020 104: 1535–41 .
   PubMed Web of Science ®Google Scholar
• Hammond CJ, Snieder H, Spector TD, et al. Factors affecting pupil size after dilatation: the Twin Eye Study. Br J Ophthalmol 2000; 84: 1173–1176.
   PubMed Web of Science ®Google Scholar
• Wilcox CS, Heiser JF, Crowder AM, et al. Comparison of the effects on pupil size and accommodation of three regimens of topical dapiprazole. Br J Ophthalmol 1995; 79: 544–548.
   PubMed Web of Science ®Google Scholar